ENTO: Entero Therapeutics Inc. Company Short-Term Debt

The daily price chart for Entero Therapeutics, Inc. (ENTO) allows for an assessment of the debt load of a company whose scaling model is based on outsourcing the production of approved patents to extract high profits. Management is focusing on the integration of new assets and cystic fibrosis therapy with celiac disease, while the indicator stands at 0.00. The technology stack relies on the automation of clinical data analysis and the implementation of robotic molecule screening.

ENTO (enterothera.com) Company Short-Term Debts history from 05/18/2024 to 12/01/2025

Analytical breakdowns for Entero Therapeutics, Inc.

- current quotes and average value forecast:
Price Chart Entero|ENTO - Fair Value Consensus
- market capitalization information:
Market Value Entero Therapeutics, Inc.|ENTO - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Entero Therapeutics|ENTO - Book Capitalization|Market Cap to Net Assets Ratio enterothera.com|ENTO - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Entero Therapeutics, Inc.|ENTO - Long-Term Indebtedness to Equity|Short-Term Debt to Capital Entero|ENTO - Company Total Debt Obligations|Debt to Book Value Entero Therapeutics, Inc.|ENTO - Amount of Long-Term Liabilities|Company Short-Term Debts Entero Therapeutics|Quick Liquidity enterothera.com
- net income and valuation multiples indicators:
ENTO - Company Profit
Fundamental company analysis:enterothera.com - ENTO

Short-term debt measures the total volume of obligations with a maturity of up to one year, allowing for an assessment of liquidity risk and working capital management efficiency. By analyzing historical short-term debt data, an investor can correlate the debt load with the reliability of Entero Therapeutics, Inc. (ENTO) logistics chains, confirming the company's ability to seamlessly supply the production of gastrointestinal drugs without cash flow gaps.

Who Entero Therapeutics, Inc. competes with

PHAT - Company Short-Term Debt|Company Short-Term Loans and Borrowings TERN (Terns Pharma)|ironwoodpharma.com (IRWD) - Company Short-Term Debt|Company Current Liabilities Curanex Pharmaceuticals|IMRN (Immuron Ltd) - Company Short-Term Debts|Company Short-Term Debts evokepharma.com|Company Current Liabilities RDHL (RedHill Biopharma)|PALI (palisadebio.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts JAGX (Jaguar Animal Health)|Short-Term Indebtedness Biora Therapeutics, Inc|Morphic Holding, Inc. - Company Short-Term Debts